These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 26475394

  • 1. Serum level of interleukin-17A in patients with alopecia areata and its relationship to age.
    El-Morsy EH, Eid AA, Ghoneim H, Al-Tameemi KA.
    Int J Dermatol; 2016 Aug; 55(8):869-74. PubMed ID: 26475394
    [Abstract] [Full Text] [Related]

  • 2. Correlation between serum IL-17A level and SALT score in patients with alopecia areata before and after NB-UVB therapy.
    Morsy H, Maher R, Negm D.
    J Cosmet Dermatol; 2018 Jun; 17(3):533-537. PubMed ID: 29707896
    [Abstract] [Full Text] [Related]

  • 3. SERUM LEVELS OF IL-2 AND IL-17A ARE RELATED TO CLINICAL TYPE AND SEVERITY OF ALOPECIA AREATA.
    Aljabali MA, Kuts L.
    Wiad Lek; 2022 Jun; 75(1 pt 2):263-267. PubMed ID: 35182133
    [Abstract] [Full Text] [Related]

  • 4. The profile of cytokines (IL-2, IFN-γ, IL-4, IL-10, IL-17A, and IL-23) in active alopecia areata.
    Gautam RK, Singh Y, Gupta A, Arora P, Khurana A, Chitkara A.
    J Cosmet Dermatol; 2020 Jan; 19(1):234-240. PubMed ID: 31087753
    [Abstract] [Full Text] [Related]

  • 5. T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-α) in patients with alopecia areata: association with clinical type and severity.
    Atwa MA, Youssef N, Bayoumy NM.
    Int J Dermatol; 2016 Jun; 55(6):666-72. PubMed ID: 26235375
    [Abstract] [Full Text] [Related]

  • 6. Elucidating the role of T-Reg related cytokines: serum transforming growth factor beta and interleukin-35 in alopecia areata.
    Yuksek T, Gonul M, Kartal SP, Gungor EB, Hatil SI.
    Arch Dermatol Res; 2024 May 24; 316(6):205. PubMed ID: 38787409
    [Abstract] [Full Text] [Related]

  • 7. T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata.
    Tembhre MK, Sharma VK.
    Br J Dermatol; 2013 Sep 24; 169(3):543-8. PubMed ID: 23607748
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of serum zinc level in patients with newly diagnosed and resistant alopecia areata.
    Abdel Fattah NS, Atef MM, Al-Qaradaghi SM.
    Int J Dermatol; 2016 Jan 24; 55(1):24-9. PubMed ID: 26147750
    [Abstract] [Full Text] [Related]

  • 9. B cell activating factor and T-helper 17 cells: possible synergistic culprits in the pathogenesis of Alopecia Areata.
    Elela MA, Gawdat HI, Hegazy RA, Fawzy MM, Abdel Hay RM, Saadi D, Shaker O.
    Arch Dermatol Res; 2016 Mar 24; 308(2):115-21. PubMed ID: 26796544
    [Abstract] [Full Text] [Related]

  • 10. Increased serum interleukin- 17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata.
    Thi Thuy Le T, Tat Nguyen T, Nguyen CTH, Trong Nguyen H, The Van T.
    Dermatol Reports; 2022 Jun 16; 14(2):9398. PubMed ID: 35795831
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata.
    Aşkın Ö, Yücesoy SN, Coşkun E, Engin B, Serdaroğlu S.
    An Bras Dermatol; 2021 Jun 16; 96(5):551-557. PubMed ID: 34281739
    [Abstract] [Full Text] [Related]

  • 12. Serum concentrations of IL-2, IL-6, IL-12 and TNF-α in patients with alopecia areata.
    Rossi A, Cantisani C, Carlesimo M, Scarnò M, Scali E, Mari E, Garelli V, Maxia C, Calvieri S.
    Int J Immunopathol Pharmacol; 2012 Jun 16; 25(3):781-8. PubMed ID: 23058031
    [Abstract] [Full Text] [Related]

  • 13. Serum IL-17A in newly diagnosed treatment-naive patients with ulcerative colitis reflects clinical disease severity and predicts the course of disease.
    Ohman L, Dahlén R, Isaksson S, Sjöling A, Wick MJ, Sjövall H, Van Oudenhove L, Simrén M, Strid H.
    Inflamm Bowel Dis; 2013 Oct 16; 19(11):2433-9. PubMed ID: 23966065
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of macrophage migration inhibitory factor (MIF) levels in serum and lesional skin of patients with alopecia areata.
    Salem SA, Asaad MK, Elsayed SB, Sehsah HM.
    Int J Dermatol; 2016 Dec 16; 55(12):1357-1361. PubMed ID: 27420731
    [Abstract] [Full Text] [Related]

  • 15. Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity.
    El Aziz Ragab MA, Hassan EM, El Niely DAEM, Mohamed MM.
    Postepy Dermatol Alergol; 2020 Dec 16; 37(6):904-908. PubMed ID: 33603607
    [Abstract] [Full Text] [Related]

  • 16. Serum cytokine and chemokine profiles in patients with alopecia areata.
    Bilgic O, Sivrikaya A, Unlu A, Altinyazar HC.
    J Dermatolog Treat; 2016 Dec 16; 27(3):260-3. PubMed ID: 26367497
    [Abstract] [Full Text] [Related]

  • 17. Serum vitamin D level is related to disease severity in pediatric alopecia areata.
    Unal M, Gonulalan G.
    J Cosmet Dermatol; 2018 Feb 16; 17(1):101-104. PubMed ID: 28447433
    [Abstract] [Full Text] [Related]

  • 18. Clinical significance of serum high-mobility group box 1 level in alopecia areata.
    Lee Y, Lee HE, Shin JM, Sohn KC, Im M, Kim CD, Seo YJ, Lee YH, Lee JH.
    J Am Acad Dermatol; 2013 Nov 16; 69(5):742-747. PubMed ID: 23932647
    [Abstract] [Full Text] [Related]

  • 19. Elevated serum tumour necrosis factor-like weak inducer of apoptosis in alopecia areata: a possible marker of disease severity.
    Sayed K, Mohammed F, Abdel Hay R, Ezzeldin N, Rashed L, Fahim A.
    Clin Exp Dermatol; 2020 Jun 16; 45(4):426-431. PubMed ID: 31587331
    [Abstract] [Full Text] [Related]

  • 20. Serum level of macrophage migration inhibitory factor (MIF) in Egyptians with alopecia areata and its relation to the clinical severity of the disease.
    Younan DN, Agamia N, Elshafei A, Ebeid N.
    J Clin Lab Anal; 2015 Jan 16; 29(1):74-9. PubMed ID: 24687398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.